Effect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes
Data assessed from 17 clinical trials of anti-amyloid drugs found no ‘meaningful effect’ on cognitive decline
Drugs that have been hailed as a gamechanger for the treatment of Alzheimer’s disease make no noticeable difference to patients, according to an extensive review.
The analysis of clinical trials in people with mild cognitive impairment or mild dementia found that the effects of anti-amyloid drugs on cognition and dementia severity over 18 months were “trivial”, with improvements in functional ability “small at best”.
https://www.theguardian.com/society/2026/apr/16/effect-gamechanger-alzheimers-drugs-trivial-review-concludes">Continue reading...Alzheimer's Drugs Benefits Questioned
- These new Alzheimer’s drugs could transform treatment The i Paper —
- Newsletter Exclusive: How to reduce your brain's biological age in just three months, by a world-leading neurologist whose regime is clinically proven to work. Use our interactive brain calculator - and follow the guide Daily Mail —
- Dementia drugs hailed as 'beginning of the end' for Alzheimer's do not work, major report finds Daily Mail —
- Alzheimer's drugs make 'no meaningful difference' RTE —
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC News —